Accent Therapeutics Competitors and Similar CompaniesClear all
Accent Therapeutics's competitors and similar companies include GlycoMimetics and Progenics Pharmaceuticals.
 Accent Therapeutics Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients. | |
Founding Date | Founding Date 2017 | Founding Date 2003 | Founding Date 1986 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Lexington, US HQ | Locations Rockville, US HQ | Locations New York, US HQ Billerica, US |
Employees | Employees 582% increase | Employees 5025% increase | Employees 52 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $10k (FY, 2023) | Revenue (est.) $35m (FY, 2019) |
Net income | Net income N/A | Net income ($36.9m) (FY, 2023) | Net income ($68.6m) (FY, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 103m | Total funding raised $ 101.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View companyProgenics Pharmaceuticals
HQ
New York, US
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
View company